Catamaran Bio is a newly-formed biotechnology company funded by SV Health Investors. Our mission is to harness the power of our innovative TAILWIND™ Platform to develop safe and effective, off-the-shelf, allogeneic immune cell therapies for the treatment of patients with cancer and immune disorders.